Moderna Japan and Tohoku University’s Tohoku Medical Megabank Organization (ToMMo) have kicked off a joint study to unravel the epidemiology of infections with two common latent viruses - cytomegalovirus (CMV) and Epstein-Barr virus (EBV). The study, announced by Moderna on…
To read the full story
Related Article
- Moderna, Tohoku University Link Up for Next-Gen Healthcare
March 14, 2023
BUSINESS
- Hisamitsu Starts Promotion of Yaz AGs under Bayer Alliance
March 11, 2026
- Seagen ADC Patent Dispute Ends with Daiichi Sankyo Victory
March 11, 2026
- Seikagaku Re-Files Herniated Disk Drug with US FDA
March 11, 2026
- Lotte to Step Up CVC Investments to Drive CDMO Synergies
March 10, 2026
- Ipsen to Withdraw Tazverik Overseas over Secondary Cancer Risk
March 10, 2026
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…





